Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022015 bond Code: 113585 bond abbreviation: Shouxian convertible bond
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
Announcement on reappointment of accounting firm
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Name of accounting firm to be employed: Lixin Certified Public Accountants (special general partnership)
1、 Basic information of the accounting firm to be employed
(I) institutional information
1. Basic information
Lixin Certified Public Accountants (special general partnership) (hereinafter referred to as “Lixin”) was founded in Shanghai in 1927 by Dr. pan Xulun, a Chinese accounting leader, and reopened in 1986. In 2010, it became the first special general partnership certified public accountants firm in China to complete the restructuring. Its registered address is Shanghai and its chief partner is Mr. Zhu Jiandi. As a member of the international accounting network BDO, Lixin has been engaged in securities service business for a long time. Before the implementation of the new securities law, it has a securities and futures business license, has H-share audit qualification, and has been registered with the American public company accounting supervision board (PCAOB).
By the end of 2021, Lixin had 252 partners, 2276 certified public accountants, 9697 employees, and 707 certified public accountants who had signed the audit report of securities service business.
In 2020, the business income (audited) of Lixin was 4.106 billion yuan, including 3.431 billion yuan from audit business and 1.357 billion yuan from securities business.
Last year, Lixin provided annual report audit services for 587 listed companies, with an audit fee of 719 million yuan and 43 audit customers of Listed Companies in the same industry.).
2. Investor protection ability
By the end of 2021, Lixin had withdrawn 129 million yuan from the occupational risk fund, and the cumulative compensation limit of the occupational insurance purchased was 1.25 billion yuan. The relevant occupational insurance can cover the civil liability caused by audit failure. Civil liability in civil litigation related to practice in recent three years:
Litigation (Arbitration) (sued (arbitrated) litigation (Arbitration) matters litigation (Arbitration) compensation litigation (Arbitration) results) amount of each person
Investors Jinya technology and Zhou Xu are expected to be jointly and severally liable for 45 million yuan in the 2014 annual report. The professional insurance of Lixin and Lihui is sufficient to cover the amount of compensation. At present, the effective judgments have been fulfilled
Investors baoqianli and Dongbei securities were restructured in 2015, and the first instance judgment of 800000 yuan was made by Lixin on baoqianli securities, Yinxin evaluation, 2015 annual report During the period from December 30, 2016 to December 14, 2017, Lixin and other annual reports assumed 15% of the debts of investors due to Securities Misrepresentation Compensation liability: the occupational insurance insured by Lixin is sufficient to cover the amount of compensation
3. Integrity record
In the past three years, Lixin has been subject to criminal punishment, administrative punishment once, supervision and management measures 24 times, self-discipline and supervision measures and disciplinary punishment twice for its practice behavior, involving 63 employees.
(II) project member information
1. Personnel information
Name of the project: Certified Public Accountant starting to be engaged in listing time: company audit time: practice time
Project partner Deng Hongyu 20092010 2009
Signature: certified public accountant Zhang Xiaoyong 20142012 2014
Quality control reviewer Chen Yu 2007
(1) Employment of project partners in recent three years:
Name: Deng Yuhong
Time listed company name position
20202021 Betta Pharmaceuticals Co.Ltd(300558) signed accountant
20192021 signed accountant of Zhejiang Aishida Co.Ltd(002403) Electric Appliance Co., Ltd
20202021 Zhejiang Weiming Environment Protection Co.Ltd(603568) signed accountant
2021 Suzhou Iron Technology Co.Ltd(688329) signed accountant
2021 Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) signed accountant
Note: the above information refers to the main employment of project partners in recent three years.
(2) Employment of Certified Public Accountants in recent three years:
Name: Zhang Xiaoyong
Time listed company name position
20192021 Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) signed accountant
Note: the above information refers to the main employment of the signing certified public accountant in recent three years.
(3) Employment of quality control reviewer in recent three years:
Name: Chen Yu
Time listed company name position
2019 Junhe Pumps Holding Co.Ltd(603617) signed accountant
20202021 Dbappsecurity Co.Ltd(688023) signed accountant
2021 Ningbo Tip Rubber Technology Co.Ltd(605255) signed partner
20202021 Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) quality control reviewer
2. Record the independence and integrity of project team members.
The project partner, the signing certified public accountant and the quality control reviewer do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
In the past three years, the project partner, the signing certified public accountant and the project quality control reviewer have not been subject to criminal punishment due to their professional behavior, administrative punishment and supervision measures by the CSRC and its dispatched offices, industry competent departments, self-discipline supervision measures and disciplinary sanctions by self-discipline organizations such as stock exchanges and industry associations.
(III) audit fees
1. Audit fee pricing principle
Pricing is mainly based on the responsibility of professional services and the degree of professional technology investment, and comprehensively considering the experience and level of employees involved in the work, the corresponding charging rate and the working hours invested.
2. Year on year changes in audit fees
The pricing principle of audit fees is mainly based on the responsibility of professional services and the degree of professional technology investment, and comprehensively considers the experience and level of employees involved in the work, the corresponding charging rate and the working hours invested. The audit fee of the company in 2021 is 1.1 million yuan (including 800000 yuan for financial statement audit and 300000 yuan for internal control audit).
The board of directors of the company requests the general meeting of shareholders to authorize the management of the company to determine the audit fees of Lixin Certified Public Accountants (special general partnership) in 2022 according to the audit workload in 2022 and the principle of fair and reasonable pricing. 2、 Procedures to be performed by the accounting firm to be reappointed
(I) opinions of the audit committee of the board of directors
On March 30, 2022, the company held the first meeting of the audit committee of the third board of directors in 2022. The meeting deliberated and approved the proposal on renewing the company’s audit institution in 2022. The Committee believed that Lixin Certified Public Accountants (special general partnership) had a clear understanding of the company’s production and operation and financial situation, adhered to the practice principle of “independence, objectivity and impartiality” in the audit process, and carefully Carry out the audit work in a down-to-earth manner, and the audit report issued for the company objectively and fairly reflects the company’s financial situation and operating results. The committee agreed to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the company’s audit institution in 2022, responsible for the company’s financial report audit, internal control audit and other relevant audit work. And submit the matter to the 32nd meeting of the third board of directors for deliberation.
(II) prior approval opinions and independent opinions of independent directors
Prior approval opinion of independent directors: Lixin Certified Public Accountants (special general partnership) is qualified to engage in securities business and has provided audit services for the company since 2012. In the process of practice, it adheres to the audit principles of independence, objectivity and impartiality. During its tenure as the company’s audit institution, it has followed the independent audit standards for Chinese certified public accountants, performed its audit work diligently, conscientiously and solidly, The audit work of the company has been well completed. To sum up, we unanimously agree to submit the matter to the 32nd meeting of the third board of directors of the company for review
Independent opinions of independent directors: Lixin Certified Public Accountants (special general partnership) is qualified to carry out securities and futures related businesses. During his tenure as the company’s audit institution, he followed the independent audit standards for Chinese certified public accountants, diligently and conscientiously carried out the audit work, and the audit report issued for the company objectively and fairly reflected the company’s financial status and operating results. The company has fulfilled the necessary procedures for renewing the appointment of accounting firm, and we unanimously agree to renew the appointment of Lixin Accounting firm (special general partnership) as the company’s audit institution in 2022.
(III) deliberations of the board of directors
On March 31, 2022, the company held the 32nd meeting of the third board of directors. The meeting considered and adopted the proposal on renewing the company’s 2022 audit institution by 9 votes in favor, 0 votes against and 0 abstentions, and agreed to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the company’s 2022 audit institution, The general meeting of shareholders is also requested to authorize the management to determine its audit remuneration in 2022 according to the specific conditions of the annual audit and the market price level.
(IV) the appointment of an accounting firm needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation, and will take effect from the date of deliberation and approval by the general meeting of shareholders of the company.
It is hereby announced.
Filing documents
(I) Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) resolution of the 32nd meeting of the third board of directors
(II) Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) independent directors’ prior approval opinions on matters related to the 32nd session of the third board of directors
(III) Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) independent directors’ independent opinions on matters related to the 32nd meeting of the third board of directors (IV) Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) resolution of the first meeting of the audit committee of the third board of directors in 2022
(V) explanation on the basic information of the proposed accounting firm
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors April 1, 2022
